<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="197748">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00516516</url>
  </required_header>
  <id_info>
    <org_study_id>HS-06-00233</org_study_id>
    <nct_id>NCT00516516</nct_id>
  </id_info>
  <brief_title>Oral Carnitine for Cramps in Pregnancy</brief_title>
  <official_title>Oral L-Carnitine for the Treatment of Muscle Cramps in Pregnancy: A Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Health Research Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Southern California</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Muscle cramps occur frequently among pregnant women, and few therapeutic options exist. This
      is a study of oral L-carntine, a dietary supplement, for the treatment of muscle cramps in
      pregnancy. Our hypothesis is that carnitine will alleviate or eliminate muscle cramps
      experienced by pregnant women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Muscle cramps occur frequently among pregnant women, and few therapeutic options exist. This
      is a study of oral L-carntine, a dietary supplement, for the treatment of muscle cramps in
      pregnancy. The conceptual basis for this study comes from the fact that carnitine has been
      used effectively in multiple randomized trials for the treatment of muscle cramps in other
      carnitine deficient states (such as hemodialysis). In pregnancy, women have decreased serum
      carnitine concentrations (from decreased intake, increased clearance by the kidney, and
      increased demands from the fetus). Thus, our hypothesis is that carnitine will alleviate or
      eliminate muscle cramps experienced by pregnant women.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>August 2007</start_date>
  <completion_date type="Anticipated">January 2008</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete elimination of muscle cramps</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Muscle Cramp</condition>
  <arm_group>
    <arm_group_label>I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral L-Carnitine, 1g PO twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>II</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo, similar in appearance to experimental drug, given orally twice daily.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>L-Carnitine</intervention_name>
    <description>L-Carnitine, 1g orally, twice daily</description>
    <arm_group_label>I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo, similar in appearance to study tablets, given orally, twice daily.</description>
    <arm_group_label>II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 16 or older

          -  Gestational Age 12 to 33 weeks

          -  Occurrence of muscle cramps at least once weekly

          -  Ability to tolerate oral L-Carnitine

          -  Ability / willingness to provide informed consent in English or Spanish

        Exclusion Criteria:

          -  Prior treatment for muscle cramps during this pregnancy

          -  Chronic muscle cramps prior to pregnancy

          -  Magnesium administration beyond that contained in prenatal vitamins

          -  History of seizures

          -  History of Pre-term delivery before 36 weeks gestational age

          -  Inability to tolerate oral L-Carnitine (e.g. hyperemesis gravidarum)

          -  Inability or unwillingness to provide informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emiliano R Chavira, MD,MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southern California, Keck School of Medicine, Division of Maternal-Fetal Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Grace H Kong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southern California, Keck School of Medicine, Division of Maternal-Fetal Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas M Goodwin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southern California, Keck School of Medicine, Division of Maternal-Fetal Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emiliano R Chavira, MD, MPH</last_name>
    <phone>(626) 826-6456</phone>
    <email>echavira@usc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Grace H Kong, MD</last_name>
    <phone>(213) 919-5553</phone>
    <email>Grace.Kong@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>USC Perinatal Group Medical Office</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Emiliano R Chavira, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USC Perinatal Group Medical Office</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Emiliano R Chavira, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Women's &amp; Children's Hospital Midwife Clinic</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Emiliano R Chavira, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2007</verification_date>
  <lastchanged_date>August 14, 2007</lastchanged_date>
  <firstreceived_date>August 14, 2007</firstreceived_date>
  <keyword>muscle cramp</keyword>
  <keyword>pregnancy</keyword>
  <keyword>carnitine</keyword>
  <keyword>randomized controlled clinical trials</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Muscle Cramp</mesh_term>
    <mesh_term>Spasm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
